| Honorific Prefix: | Sir |
| Simon Campbell | |
| Birth Name: | Simon Fraser Campbell |
| Birth Date: | 27 March 1941 |
| Birth Place: | Lapal, England, United Kingdom |
| Alma Mater: | University of Birmingham (BSc, PhD) |
| Thesis Title: | Elimination processes in polyfluorocycloalkanes |
| Thesis Url: | http://www.theses.com |
| Thesis Year: | 1966 |
| Doctoral Advisors: | )--> |
| Spouses: | )--> |
| Partners: | )--> |
Sir Simon Fraser Campbell, (born 27 March 1941) is a British chemist.
Campbell was born on 27 March 1941 in Lapal, England.[1] He obtained a first-class BSc degree in Chemistry in 1962, a PhD degree in 1965, and an honorary DSc degree in 2004 from the University of Birmingham .
He was President of the Royal Society of Chemistry from 2004 to 2006.[2] He led innovative research, discovering some of the world's best-selling prescription drugs, including sildenafil, amlodipine, and doxazosin.[3] He was visiting lecturer at Universidade de São Paulo. He was a medicinal chemist for Pfizer.[4] He was visiting professor at University of Leeds, and on the advisory board of University of Kent, and University of Bristol.[5]
Campbell was knighted in the 2015 New Year Honours for services to chemistry,[6] having previously been made a Commander of the Order of the British Empire (CBE).